Informationen:
Fehler:
ID
13207
Beschreibung
Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00183989
Link
https://clinicaltrials.gov/show/NCT00183989
Stichworte
Versionen (1)
- 24.01.16 24.01.16 -
Hochgeladen am
24. Januar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Mantle Cell Lymphoma NCT00183989
Eligibility Mantle Cell Lymphoma NCT00183989
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Mantle Cell Lymphoma NCT00183989
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
pathology mantle cell lymphoma
Item
pathologic diagnosis of non-hodgkin's lymphoma of the mantle cell sub-type lymphoma only, as determined by morphologic assessment and consistent immunophemotypic markers
boolean
C0030664 (UMLS CUI [1,1])
C0334634 (UMLS CUI [1,2])
C0334634 (UMLS CUI [1,2])
diagnosis, treatment
Item
newly diagnosed and patients who have received prior treatment are eligible
boolean
C0011900 (UMLS CUI [1])
C0087111 (UMLS CUI [2])
C0087111 (UMLS CUI [2])
measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
C1516986 (UMLS CUI [2])
karnofsky
Item
karnofsky performance status greater or equal to 50%
boolean
C0206065 (UMLS CUI [1])
gender, age
Item
men and women, age greater or equal to 18 years old
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
granulocytes, platelets, hb
Item
agc greater or equal to 1.0; platelets greater or equal to 75,000; hemoglobin greater or equal to 8.0 (unless because of lymphomatous infiltration of the marrow)
boolean
C0857490 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
creatinine, bilirubin, ast
Item
creatinine less than 2.0; bilirubin less than 2.0; sgot less than 3 times upper limit of normal (unless elevations are due to lymphomatous involvement)
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
pregnancy tes
Item
women of child bearing potential must have negative pregnancy test within 14 days of study entry.
boolean
C0032976 (UMLS CUI [1])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
cardiac disease
Item
history of congestive heart failure or significant cardiac disease
boolean
C0018799 (UMLS CUI [1])
fludarabine, mitoxantrone
Item
prior exposure to either fludarabine or mitoxantrone. prior exposure to rituximab allowed
boolean
C0059985 (UMLS CUI [1])
C0026259 (UMLS CUI [2])
C0026259 (UMLS CUI [2])
infection
Item
active infection
boolean
C0009450 (UMLS CUI [1])
hiv
Item
hiv seropositive
boolean
C0019682 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating females
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
malignancy
Item
second active malignancy, other than squamous cell skin cancer,in-situ cervical cancer, or history of other cancer diagnosed within the preceding 5 years
boolean
C0006826 (UMLS CUI [1])
mental disorders
Item
presence of psychological or emotional disorders which would make valid informed consent impossible
boolean
C0004936 (UMLS CUI [1])